comparemela.com

Latest Breaking News On - Kim hazen - Page 1 : comparemela.com

Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results

03.03.2022 - – Clear path forward for Phase 3 REACH trial with losmapimod in FSHD; Trial expected to begin in 2Q 2022 – – On track to report initial data from Phase 1b trial with FTX-6058 in sickle cell disease in 2Q 2022 – – Conference call scheduled for .

Cambridge
Cambridgeshire
United-kingdom
Canada
United-states
Kaitlin-gallagher
Bryan-stuart
Stephanie-ascher
Naomi-aoki
Christi-waarich
Stern-investor-relations-inc
Drug-administration

vimarsana © 2020. All Rights Reserved.